880122 | DSPE-PEG(2000) Cyanur
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[cyanur(polyethylene glycol)-2000] (ammonium salt)
Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
DSPE-PEG(2000) Cyanur
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[cyanur(polyethylene glycol)-2000] (ammonium salt)
Cyanur PEG-PE is an endgroup functionalized PEG-lipid conjugate used for attachment of peptides, antibodies, etc., under mild basic conditions. Proteins can be coupled to this membrane anchor without the need for previous derivatization.
Representative Structure
The formula weight and exact mass are averages based on the polydispersity of PEG.
C135H265Cl2N6O54P (average MW due to polydispersity of PEG)
C 55.18%, H 9.09%, Cl 2.41%, N 2.86%, O 29.40%, P 1.05%
CAS Registry Number is a Registered Trademark of the American Chemical Society
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[carbonyl-amino(polyethylene glycol)-2000-N’-(6-(2,4-dichloro-1,3,5-triazinyl)] (ammonium salt)
Powered by BiozKheradmandi M, Ackers I, Burdick MM, Malgor R, Farnoud AM. Targeting Dysfunctional Vascular Endothelial Cells Using Immunoliposomes Under Flow Conditions. Cell Mol Bioeng. 2020 May 4;13(3):189-199. doi: 10.1007/s12195-020-00616-1. PMID: 32426057; PMCID: PMC7225235.
PubMed ID: 32426057Bakowsky H, Richter T, Kneuer C, Hoekstra D, Rothe U, Bendas G, Ehrhardt C, Bakowsky U. Adhesion characteristics and stability assessment of lectin-modified liposomes for site-specific drug delivery. Biochim Biophys Acta. 2008 Jan;1778(1):242-9. doi: 10.1016/j.bbamem.2007.09.033. Epub 2007 Oct 10. PMID: 17964278.
PubMed ID: 17964278Bendas G, Krause A, Bakowsky U, Vogel J, Rothe U. Targetability of novel immunoliposomes prepared by a new antibody conjugation technique. Int J Pharm. 1999 Apr 20;181(1):79-93. doi: 10.1016/s0378-5173(99)00002-2. PMID: 10370205.
PubMed ID: 10370205- Certificate of Analysis (Lot No. 880122P-10MG-A-015 and 6285PIA015)
- Certificate of Analysis (Lot No. 880122P-50MG-A-015 and 6285PIA015)
- Certificate of Analysis (Lot No. 880122P-10MG-B-015 and 6285PIB015)
- Certificate of Analysis (Lot No. 880122P-10MG-C-015 and 6285PIC015)
